Home Services Pharmacoeconomics & Outcomes Research

Pharmacoeconomics & Outcomes Research




Research programs designed for cost-benefit and economic issues relating to clinical use of drugs and devices, and therapeutic or treatment approaches. Quality-of-life research, therapeutic outcomes, evidence based medicine.


Within the framework of our CRO services, and available to every clinical development program we design and manage, we touch upon the pharmacoeconomic and health economic components.  At various stages in the development cycle, a program can potentially benefit from a proper review of outcomes analysis.


Working with device manufacturers, pharmaceutical companies, healthcare companies, we design and manage a variety of outcomes programs, including global trials, and registry studies.  Using modern available resources, today, conduting far-reaching post marketing studies offering unprecedented cost-effectiveness data is within every programs reach.  Outcomes Data, Quality of Life Studies, Patient Subpopulation Studies, Postmarketing Surveillance of Medical Devices, Reimbursement Models. 





News & Events

  • Statins May Slow Progression Of Multiple Sclerosis, New Study Finds A UCSF-led study exa... Read more>>
  • Key Protein Aids In DNA Repair Scientists have shown in multiple contexts that DNA damage ov... Read more>>
  • Pending Litigation to Delay Launch of Generic Asacol Boehringer Ingelheim’s Roxane Laboratori... Read more>>
  • FDA Requests More Information on Certriad LONDON (AP) - AstraZeneca PLC and Abbott Laborator... Read more>>
  • New Class of Brain-Protecting Drugs Emerging Researchers have identified a compound that mim... Read more>>
  • in vivo Pharmacodynamic Assay Trevigen offers a validated assay with higher sensitivity and... Read more>>
  • GSK Receives EMEA Approval for Duodart LONDON (AP) - Pharmaceutical company GlaxoSmithKline... Read more>>
  • T Cell Proliferation Assays ProImmune Ltd, a leader in epitope discovery, immunogenicity, an... Read more>>
  • FDA Says Additional Pixuvri Trial Needed, CTI Opens Drug to Expanded Access Cell Therapeutics... Read more>>
  • FDA Approves Mylan’s Drug Applications Mylan Inc. Monday announced that its subsidiary Mylan Ph... Read more>>
  • Food and Drug Administration NOTICES Meetings:   Internationa... Read more>>
  • AllTranz Developing Multi-Use Transdermal Patch   AllTranz, Lexington, Ky., is focused on t... Read more>>